A Prospective Study of Risk Factors for Bacterial Vaginosis in HIV-1-Seronegative African Women

Background: Bacterial vaginosis (BV) is common and has been associated with increased HIV-1 susceptibility. The objective of this study was to identify risk factors for BV in African women at high risk for acquiring HIV-1. Methods: We conducted a prospective study among 151 HIV-1-seronegative Kenyan female sex workers. Nonpregnant women were eligible if they did not have symptoms of abnormal vaginal itching or discharge at the time of enrollment. At monthly follow-up, a vaginal examination and laboratory testing for genital tract infections were performed. Multivariate Andersen-Gill proportional hazards analysis was used to identify correlates of BV. Results: Participants completed a median of 378 (interquartile range 350–412) days of follow-up. Compared with women reporting no vaginal washing, those who reported vaginal washing 1 to 14 [adjusted hazard ratio (aHR) 1.29, 95% confidence interval (CI) 0.88–1.89], 15 to 28 (aHR 1.60, 95% CI 0.98–2.61), and >28 times/wk (aHR 2.39, 95% CI 1.35–4.23) were at increased risk of BV. Higher BV incidence was also associated with the use of cloth for intravaginal cleansing (aHR 1.48, 95% CI 1.06–2.08) and with recent unprotected intercourse (aHR 1.75, 95% CI 1.47–2.08). Women using depot medroxyprogesterone acetate contraception were at lower risk for BV (aHR 0.59, 95% CI 0.48–0.73). Conclusions: Vaginal washing and unprotected intercourse were associated with increased risk of BV. These findings could help to inform the development of novel vaginal health approaches for HIV-1 risk reduction in women.

[1]  M. Klebanoff,et al.  Longitudinal Association Between Hormonal Contraceptives and Bacterial Vaginosis in Women of Reproductive Age , 2007, Sexually transmitted diseases.

[2]  R. Ness,et al.  Vaginal Douching and Development of Bacterial Vaginosis Among Women With Normal and Abnormal Vaginal Microflora , 2007, Sexually transmitted diseases.

[3]  R. McClelland,et al.  Associations Between Intravaginal Practices and Bacterial Vaginosis in Kenyan Female Sex Workers Without Symptoms of Vaginal Infections , 2006, Sexually transmitted diseases.

[4]  R. Ness,et al.  Variability of Bacterial Vaginosis Over 6- to 12-Month Intervals , 2006, Sexually transmitted diseases.

[5]  S. Garland,et al.  High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. , 2006, The Journal of infectious diseases.

[6]  J. Marrazzo A persistent(ly) enigmatic ecological mystery: bacterial vaginosis. , 2006, The Journal of infectious diseases.

[7]  J. Baeten,et al.  Vaginal washing and increased risk of HIV-1 acquisition among African women: a 10-year prospective study , 2006, AIDS.

[8]  G. Reid,et al.  Lactobacillus Vaginal Microbiota of Women Attending a Reproductive Health Care Service in Benin City, Nigeria , 2006, Sexually transmitted diseases.

[9]  L. Myer,et al.  Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and biological mechanisms. , 2005, The Lancet. Infectious diseases.

[10]  J. Marrazzo,et al.  Molecular identification of bacteria associated with bacterial vaginosis. , 2005, The New England journal of medicine.

[11]  Michelle de Souza,et al.  Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. , 2005, The Journal of infectious diseases.

[12]  J. Baeten,et al.  Contribution of HIV-1 infection to acquisition of sexually transmitted disease: a 10-year prospective study. , 2005, The Journal of infectious diseases.

[13]  M. Hammarström,et al.  Influence of Hormonal Contraceptives on the Immune Cells and Thickness of Human Vaginal Epithelium , 2003, Obstetrics and gynecology.

[14]  M. Krohn,et al.  Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  J. Baeten,et al.  Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. , 2001, American journal of obstetrics and gynecology.

[16]  J. H. van de Wijgert,et al.  Intravaginal practices, vaginal flora disturbances, and acquisition of sexually transmitted diseases in Zimbabwean women. , 2000, The Journal of infectious diseases.

[17]  B. Chohan,et al.  Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. , 1999, The Journal of infectious diseases.

[18]  J. Schwebke,et al.  Correlation of behaviors with microbiological changes in vaginal flora. , 1999, The Journal of infectious diseases.

[19]  B. Richardson,et al.  Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. , 1998, The Journal of infectious diseases.

[20]  D R Hoover,et al.  Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV , 1998, AIDS.

[21]  J. Peipert,et al.  Bacterial vaginosis as a risk factor for upper genital tract infection. , 1997, American journal of obstetrics and gynecology.

[22]  K. Holmes,et al.  Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. , 1996, The Journal of infectious diseases.

[23]  Mary Frances Cotch,et al.  Association between Bacterial Vaginosis and Preterm Delivery of a Low-Birth-Weight Infant , 1995 .

[24]  M A Krohn,et al.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation , 1991, Journal of clinical microbiology.

[25]  F. Barbone,et al.  A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis. , 1990, American journal of obstetrics and gynecology.

[26]  E. Belsey Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception. , 1988, Contraception.

[27]  R. Edelman,et al.  "Association between Bacterial Vaginosis and Preterm Delivery of a Low- birth-weight Infant." , 1996 .

[28]  K. Holmes,et al.  A dose-duration study of metronidazole for the treatment of nonspecific vaginosis. , 1983, Scandinavian journal of infectious diseases. Supplementum.

[29]  K. Holmes,et al.  Nonspecific vaginitis: Diagnostic criteria and microbial and epidemiologic associations , 1983 .